Drug Type Small molecule drug |
Synonyms ABT 384 |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H34F3N5O2 |
InChIKeyCLHMYBJIOZXCEX-UHFFFAOYSA-N |
CAS Registry868623-40-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | Russia | 01 May 2010 | |
Alzheimer Disease | Phase 2 | South Africa | 01 May 2010 | |
Alzheimer Disease | Phase 2 | Ukraine | 01 May 2010 | |
Alzheimer Disease | Phase 2 | United Kingdom | 01 May 2010 |